Jake Mintz and Jordan Shusterman dig into what is going wrong with the Yankees, who was selected as an All-Star starter and ...
The Food and Drug Administration approved Eli Lilly’s Kisunla on Tuesday for mild or early cases of dementia caused by ...
The Food and Drug Administration on Tuesday approved Eli Lilly’s Alzheimer’s drug, the company announced, clearing the way ...
The agency determined that the potential of slowing the devastating disease in patients with mild cognitive impairment ...
The FDA approved the experimental Alzheimer's drug donanemab. The drug will be sold under the brand name Kisunla.
Alzheimer’s drug that can slow the disease by several months. FDA approves a second Alzheimer’s drug that can slow the ...
According to the Alzheimer's Association, more than 129,000 people aged 65 and older have Alzheimer's disease in Tennessee.
The Food and Drug Administration approved a new Alzheimer's treatment ... anti-amyloid treatments greenlighted by the FDA to date for Alzheimer's already carry a boxed warning about "amyloid ...
The Food and Drug Administration announced Tuesday the approval of a new Alzheimer ’s drug from Eli Lilly, which has demonstrated moderately slow cognitive and memory decline in patients with the ...
The FDA approved Kisunla, known chemically as donanemab ... aren’t yet setup to prescribe the new plaque-targeting Alzheimer's drugs. First, doctors need to confirm that patients with dementia ...
The U.S. Food and Drug Administration (FDA) has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults ...